Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

Eur J Haematol. 2010 Oct;85(4):363-5. doi: 10.1111/j.1600-0609.2010.01500.x. Epub 2010 Aug 30.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Combined Modality Therapy
  • Dexamethasone* / administration & dosage
  • Dexamethasone* / adverse effects
  • Female
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • Multiple Myeloma / pathology
  • Multiple Myeloma / physiopathology
  • Multiple Myeloma / therapy*
  • Renal Dialysis
  • Retrospective Studies
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Treatment Outcome

Substances

  • Thalidomide
  • Dexamethasone
  • Lenalidomide